Janssen’s single-shot Covid-19 vaccine granted full approval in Canada
J&J’s single-shot vaccine showed 85% protection against Covid-19 related hospitalisation and death, and across different variants
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Nov 21
J&J’s single-shot vaccine showed 85% protection against Covid-19 related hospitalisation and death, and across different variants
24 Nov 21
Livtencity is an orally bioavailable anti-CMV compound that works by blocking the activity of the human cytomegalovirus enzyme…
24 Nov 21
The EC marketing authorisation was based on results from the Phase 3 ASCENT study of Trodelvy in people…
22 Nov 21
Gavreto is a once-daily, oral precision medicine that works by selectively targeting rearranged during transfection (RET) alterations, including…
22 Nov 21
Voxzogo is the first treatment for achondroplasia, which is the most common form of disproportionate short stature, said…
18 Nov 21
The regulatory approval is supported by data from Phase 3 KEEPsAKE-1 and KEEPsAKE-2 studies, evaluating Skyrizi in psoriatic…
17 Nov 21
According to the company, Paxlovid would be the first 3CL protease inhibitor to be used as an oral…
16 Nov 21
Health Canada authorisation was based on scientific evidence shared by Moderna, including data from the Phase 2 clinical…
15 Nov 21
The EC approval follows EMA’s Committee for Medicinal Products for Human Use (CHMP) recommendation to authorise two Covid-19…
12 Nov 21
Ronapreve and Regkirona are the first monoclonal antibody medicines to receive a positive opinion from the CHMP for…